Susquehanna International Group’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $3.66M | Sell |
|
|||||
|
2025
Q2 | $4.61M | Buy |
|
|||||
|
2025
Q1 | $2.19M | Buy |
|
|||||
|
2024
Q4 | $2.92M | Buy |
|
|||||
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $295K | Buy |
|
|||||
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $1.74M | Buy |
|
|||||
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $2.15M | Sell |
|
|||||
|
2023
Q1 | $3.03M | Buy |
|
|||||
|
2022
Q4 | $1.15M | Sell |
|
|||||
|
2022
Q3 | $1.11M | Buy |
|
|||||
|
2022
Q2 | – | Sell |
|
|||||
|
2022
Q1 | $1.78M | Buy |
|
|||||
|
2021
Q4 | $1.77M | Sell |
|
|||||
|
2021
Q3 | $3.82M | Buy |
|
|||||
|
2021
Q2 | $1.27M | Buy |
|
|||||
|
2021
Q1 | $1.04M | Sell |
|
|||||
|
2020
Q4 | $1.26M | Sell |
|
|||||
|
2020
Q3 | $1.11M | Buy |
|
|||||
|
2020
Q2 | – | Hold |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2.22M | Buy |
|
|||||
|
2019
Q3 | $802K | Buy |
|
|||||
|
2019
Q2 | $284K | Buy |
|
|||||
|
2019
Q1 | $39K | Sell |
|
|||||
|
2018
Q4 | $86K | Sell |
|
|||||
|
2018
Q3 | $160K | Sell |
|
|||||
|
2018
Q2 | $315K | Sell |
|
|||||
|
2018
Q1 | $377K | Buy |
|
|||||
|
2017
Q4 | $284K | Buy |
|
|||||
|
2017
Q3 | $117K | Buy |
|
|||||
|
2017
Q2 | – | Hold |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $138K | Sell |
|
|||||
|
2016
Q3 | $233K | Buy |
|
|||||
|
2016
Q2 | $157K | Sell |
|
|||||
|
2016
Q1 | $164K | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $573K | Sell |
|
|||||
|
2015
Q2 | $2.69M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $798K | Buy |
|
|||||
|
2014
Q3 | $197K | Sell |
|
|||||
|
2014
Q2 | $1.09M | Buy |
|
|||||
|
2014
Q1 | $748K | Buy |
|
|||||
|
2013
Q4 | $371K | Buy |
|
|||||
|
2013
Q3 | $269K | Buy |
|
|||||
|
2013
Q2 | $223K | Buy |
|